Synergistic Antiviral Activity of Pamapimod and Pioglitazone Against SARS-CoV-2 and Its Variants of Concern.
International Journal of Molecular Sciences（2022）
Key words
COVID-19,SARS-CoV-2,coronavirus,variants of concern,virus variants,pioglitazone,pamapimod,p38-inhibitor,PPRy-agonist,cellular targets
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined